What Do Acquirers Want Before Buying a Device Startup?
Buyers used to purchase technology before it reached the market. Now they want to see a sales motion that works and customers who stay.
MedTech · Stage 4: Proposal to Close · Leadership
What do acquirers want to see before buying a device startup?
Proof that the product sells and stays sold. Strategic buyers look for three things: new accounts, deep adoption inside those accounts, and customers who keep buying over 24 to 36 months. They want it in a small number of markets, not 30, and they don't want to inherit a large sales force they will later let go.
Proof that the product sells and stays sold. Strategic buyers look for three things: new accounts, deep adoption inside those accounts, and customers who keep buying over time. They want to see it in a small number of markets, and they don't want to inherit a big sales force along with your technology.
That is a real change. Buyers used to come in and purchase technologies before they went to market. Now everybody wants to see a sales motion first.
What do new logos, adoption and retention look like in practice?
If I were sitting in your seat, these are the three questions I would ask every week.
- How many new accounts can I get into? And which ones should I go after first?
- Once I'm in, how deep can I go? You have already invested your way through the door. Now there is a second physician, then another department, then the sister hospitals in the same community. One sale should become an order network.
- Am I keeping them? Are the accounts that bought two years ago still buying today?
The third one is operational, and founders underestimate it. You need an infrastructure that makes it easy to reorder and easy to get a question answered. It takes about four times the time and energy to win a new customer as it does to keep one. Once you have worked that hard to create a customer, losing them is the most expensive mistake you can make.
Buyers tell me they want this shown over 24 to 36 months, in a handful of markets. They don't need 30.
How much revenue do I need before a buyer is interested?
Less than most founders assume. If you do those three things really well, you don't need $10 million, $20 million or $30 million in revenue. You might need four or five.
There is a trade-off. Selling earlier may mean a smaller exit. Maybe you sell at $7 million or $8 million in revenue instead of $30 million. But you get there sooner, you raise less along the way, and you keep more of your company.
Timing matters too. Early on, your growth curve looks like a hockey stick. At some point it starts to flatten, and buyers will ask what is happening. There is an optimal window in that life cycle, and you want to be in the conversation while the curve is still steep.
Why does the size of my sales team matter to a buyer?
Because the buyer usually already has a sales force. Most strategic buyers don't want to buy a sales organization. They want the customers, the revenue and the knowledge.
When a buyer acquires a startup with 20 or 30 reps, those people often sit for months waiting to find out what happens, and then they get a package. I estimate that can cost a buyer around $15 million in transition. I have been on that side of the table. After one acquisition, I let go of 32 people over 12 months.
So a lean commercial setup is not just cheaper for you. It makes for a cleaner deal. What a buyer does want to lift in place is your system: the CRM, the customer data, the account history. Keep that clean from day one.
What should I avoid?
- Spreading thin across many markets to look national.
- Chasing new logos while ignoring depth and reorders in existing accounts.
- Hiring a large team you will have to explain in diligence.
- Keeping customer data in reps' heads instead of your CRM.
Where should I start?
Build a simple scorecard now, even before your first sale. Track new accounts per market, the number of physicians and departments using the product in each account, and reorder rates over time. Pick a few markets where you can show all three. Review it monthly, and treat any account that stops reordering as a fire to put out that week.
Where this fits: stage 4 of the revenue funnel, Proposal to Close. Read what revenue friction is and how it is measured. See how RevRx AI works with MedTech teams.
This article shares general views on commercial strategy. It is not medical, legal, financial or regulatory advice.
Related articles
- Leadership · MedTech · Stage 4: Proposal to Close
How Much Should a Device Company Spend on Sales?
Nobody cash-flows sales and marketing in the first years of a device launch. The question is whether your ratio is heading the right way.
- Leadership · MedTech · Stage 4: Proposal to Close
Do You Lose Control When You Outsource Sales?
Every founder I talk to about an outside commercial team asks the same thing: am I giving up control? Here is how I answer it.
Sales & Teams · MedTech · Stage 4: Proposal to CloseWhy a Strong Resume Can Be Wrong for Your Startup
An impressive executive resume does not show how someone will work inside a small team. Giovanni Lauricella explains what he looks for when recruiting for venture-backed MedTech companies.
Related episodes
47:38LeadershipRecruiter and Operator: Lessons From Both Sides of the Table
Giovanni Lauricella, Lifeblood
Sep 3, 2026 (opens YouTube in a new tab)
Read the article: Why a Strong Resume Can Be Wrong for Your Startup
31:57LeadershipHow High Performers Take Care of Their Cockpit
Greg Salerian
Oct 20, 2026 (opens YouTube in a new tab)
Read the article: Why High Performers Burn Out: Take Care of the Cockpit
39:34LeadershipLiving With AFib: He Built a Company While Hiding It
Jim Kaveney, Unlimited Heart
Sep 17, 2026 (opens YouTube in a new tab)
Read the article: When a Growing Business Loses Sight of Its Purpose
Is this friction slowing your revenue?
Take the MedTech Revenue Scorecard or book a free Discovery Call.
Free 30-minute call: a commercial snapshot of your business (one strength, weakness, opportunity and threat, prepped before we talk) and your top priority fixes.